KIR2DS4, Recombinant, Human (p50 KIR, p50.3, CD158, cl39, KAR-K1, NKR-K1, Killer Cell Immunoglobulin (Ig)-like Receptor)
Catalog No : USB-K1858-60
564.38€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | KIR2DS4, Recombinant, Human (p50 KIR, p50.3, CD158, cl39, KAR-K1, NKR-K1, Killer Cell Immunoglobulin (Ig)-like Receptor) | ||
|---|---|---|---|
| Catalog No | USB-K1858-60 | ||
| Supplier’s Catalog No | K1858-60 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, E. coli | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 22.2 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ≥ 95% by SDS PAGE; Purified by FPLC gel-filtration chromatography, after refolding of the isolated inclusion bodies in a redox buffer. | ||
| Form | Supplied as a liquid in 20mM Tris-HCl, pH 7.5. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | ≥ 95% by SDS PAGE; Purified by FPLC gel-filtration chromatography, after refolding of the isolated inclusion bodies in a redox buffer. | ||
| Description | An activating Killer Cell Ig-like Receptor (KIR, previously called p50 KIR, p50.3, cl39, or KAR-K1), which may recognize class I MHC molecules. The protein coding region of the extracellular domain of KIR2DS4 (amino acids 1-202) was cloned into an E. coli expression vector. The extracellular domain of KIR2DS4 was overexpressed as insoluble protein aggregates (inclusion bodies). Molecular Weight: 22.2kD Sequence: MEGVHRKPSF/ LALPGHLVKS/ EETVILQCWS/ DVMFEHFLLH/ REGKFNNTLH/ LIGEHHDGVS/ KANFSIGPMM/ PVLAGTYRCY/ GSVPHSPYQL/ SAPSDPLDMV/ IIGLYEKPSL/ SAQPGPTVQA/ GENVTLSCSS/ RSSYDMYHLS/ REGEAHERRL/ PAVRSINGTF/ QADFPLGPAT/ HGGTYRCFGS/ FRDAPYEWSN/ SSDPLLVSVT/ GN Storage and Stability: May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
© 2020 Imugex All Rights Reserved